|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.6 TWD | +0.47% |
|
+4.85% | -20.00% |
General Biologicals Corporation reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 226.47 million compared to TWD 318.1 million a year ago. Net income was TWD 13.91 million compared to TWD 52.36 million a year ago.
Basic earnings per share from continuing operations was TWD 0.23 compared to TWD 0.88 a year ago. Diluted earnings per share from continuing operations was TWD 0.23 compared to TWD 0.88 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.00% | 39.61M | |
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.3B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B | |
| -5.02% | 1.64B |
GENERAL BIOLOGICALS CORPORATION 
